Ignite Creation Date:
2024-05-05 @ 9:42 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00944801
Status:
COMPLETED
Last Update Posted:
2009-07-23
First Post:
2009-07-17
Brief Title:
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
Sponsor:
University of Regensburg
Organization:
University of Regensburg
Organization Data
Organization:
University of Regensburg
Class:
OTHER
Study ID:
RNOP-09
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Regensburg
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Ulrich Bogdahn Prof Dr med
Old Organization:
Department of Neurology University of Regensburg
Collaborators
| Name | Class |
|---|---|
| Essex Pharma Germany | OTHER |